by Dr. C.H. Weaver 11/2023
As the month of November brings lung cancer into focus it’s important to note the great strides that have recently been made in the management of non small cell lung cancer (NSCLC) largely due to the advancement of precision cancer medicines and immunotherapy.
Lung cancer remains the second most common cancer in women (behind breast cancer) and also the second most common in men (behind prostate cancer). In 2023, there will be over 225,000 individuals diagnosed with lung cancer in the United States.
The treatment of lung cancer is rapidly evolving. To derive the most benefit from recent advances individuals diagnosed with lung cancer need to have their treatment planned and coordinated by a multidisciplinary team including the surgeon, and medical oncologist. Many patients will derive the most benefit when chemo-immunotherapy is begun BEFORE surgery and its extremely important that molecular testing of the cancer be performed on both the tumor tissue and blood to identify the best treatment.
Featured on CancerConnect
- The role of peri-operative therapy in lung cancer
- Importance of Molecular – Biomarker Testing in Lung Cancer
- Alecensa – A new treatment for early stage ALK mutated NSCLC
- Retevmo targeted therapy for RET mutated NSCLC
- Dato-Dxd – A new treatment for recurrent NSCLC
- Precision Cancer Medicines for Lung Cancer
- ESMO Update on Bispecific Antibodies and Drug Conjugates for NSCLC and Small Cell Lung Cancer
- Tagrisso First Precision Medicine Approved for early-stage NSCLC
Information and Education
- Mesothelioma Resource Center
- Lung Cancer Resource Center
- Lung Cancer Treatment News Updates
- Join the Lung Cancer Support & Information Community
Connect With Others for Support and Information
CancerConnect was the first social network created for people with breast cancer. Founded by oncologists to support myeloma patients and their caregivers, over 40 million individuals have accessed CancerConnect programs since 1997. CancerConnect is used by leading cancer centers like Dana Farber, Roswell Park and The James at Ohio State to support their patients. Join the conversation, ask questions, share your experience, and learn how the best cancer centers are treating breast cancer from others. Share your experience, ask a question, or start a conversation by posting on CancerConnect.
